Drug · DIN 02455870
MOSASPRAY
SUSPENSION
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 20, 2020; first marketed June 17, 2016.
- Drug Identification Number (DIN)
- 02455870
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Spray (Metered-Dose)
- Route
- Nasal
- Therapeutic class (ATC)
- Mometasone R01AD09
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE) | 50 MCG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 17, 2016: NOC 18188Abbreviated New Drug Submission (ANDS)